Product Images Harvoni

Harvoni tablets contain 90 mg of ledipasvir and 400 mg of sofosbuvir. They should be stored below 30 °C (86 °F). These tablets should be dispensed only in the original container. Check the package insert for dosage and administration instructions. Harvoni® (ledipasvir, sofosbuvir) tablets should be taken once daily. There is an ALERT box that should not be covered with the pharmacy label. Find out about medicines that should not be taken with Harvoni. Manufactured for Gilead Sciences Inc., Foster City, CA 94404. The text appears to be a description of the drug Harvoni.*

Harvoni tablets are a medication that consists of 45 mg of ledipasvir and 200 mg of sofosbuvir per tablet. The tablets should be stored below 30°C (86°F) and dispensed only in the original container. The recommended dosage should be referred to in the prescribing information. Harvoni is made in Canada and manufactured for Gilead Sciences, Inc. The medication comes in a package of 28 tablets. Patients should be cautioned about medicines that should not be taken with Harvoni, and the ALERT box should not be covered with a pharmacy label.*

This is a medication called Harvoni, which comes in the form of oral pellets. Each packet contains 33.75 mg of ledipasvir and 150 mg of sofosbuvir. The medication is manufactured by GILEAD. There is also a note to the pharmacist to not cover the ALERT box with the pharmacy label and to check which medications should not be taken with Harvoni.*

This is a medicine for oral consumption called Harvoni. It comes in the form of pellets contained in 28 packets, each packet having 45 mg/200 mg of ledipasvir/sofosbuvir. There is a note to the pharmacist not to cover the alert box with the pharmacy label. However, it is not clear what the alert is about due to unclear text recognition.*